Daniel Woolson's Insider Trades & SAST Disclosures
Daniel Woolson's most recent trade in ICU Medical, Inc. was a trade of 2,923 Performance Shares done . Disclosure was reported to the exchange on March 15, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Daniel Woolson.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,923 | 2,924 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2025 | 2,923 | 15,488 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 143.45 per share. | 15 Mar 2025 | 1,294 | 14,194 (0%) | 0% | 143.4 | 185,624 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2025 | 4,755 | 11,214 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,153 | 9,061 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 2,153 | 13,518 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 966 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2025 | 966 | 11,832 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.97 per share. | 07 Mar 2025 | 953 | 12,565 (0%) | 0% | 142.0 | 135,297 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 141.97 per share. | 07 Mar 2025 | 467 | 11,365 (0%) | 0% | 142.0 | 66,300 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 156.25 per share. | 06 Dec 2024 | 2,241 | 10,866 (0%) | 0% | 156.3 | 350,158 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 163.22 per share. | 30 Aug 2024 | 2,502 | 13,107 (0%) | 0% | 163.2 | 408,370 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 2,923 | 16,903 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Mar 2024 | 2,923 | 5,847 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 98.08 per share. | 15 Mar 2024 | 1,294 | 15,609 (0%) | 0% | 98.1 | 126,916 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 98.27 per share. | 15 Mar 2024 | 791 | 13,980 (0%) | 0% | 98.3 | 77,733 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Mar 2024 | 6,459 | 6,459 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 5,792 | 0 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 5,792 | 16,209 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.39 per share. | 07 Mar 2024 | 2,564 | 13,645 (0%) | 0% | 105.4 | 270,220 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,020 | 15,665 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 2,020 | 0 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 966 | 966 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Mar 2024 | 966 | 10,843 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 104.52 per share. | 07 Mar 2024 | 894 | 14,771 (0%) | 0% | 104.5 | 93,441 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 105.39 per share. | 07 Mar 2024 | 426 | 10,417 (0%) | 0% | 105.4 | 44,896 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 2,020 | 2,020 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 2,020 | 12,500 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 1,417 | 0 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 1,417 | 10,569 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 965 | 1,932 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2023 | 965 | 10,908 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 156.17 per share. | 06 Mar 2023 | 894 | 11,606 (0%) | 0% | 156.2 | 139,616 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 161.25 per share. | 06 Mar 2023 | 626 | 9,943 (0%) | 0% | 161.3 | 100,943 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 157.47 per share. | 06 Mar 2023 | 428 | 10,480 (0%) | 0% | 157.5 | 67,397 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Sale of securities on an exchange or to another person at price $ 200.00 per share. | 02 Feb 2023 | 1,731 | 9,152 (0%) | 0% | 200 | 346,200 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Mar 2022 | 2,897 | 2,897 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 2,020 | 11,777 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 2,020 | 4,040 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,444 | 9,606 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,444 | 0 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,418 | 10,385 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2022 | 1,418 | 1,417 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2022 | 894 | 10,883 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 242.93 per share. | 06 Mar 2022 | 639 | 8,967 (0%) | 0% | 242.9 | 155,232 | Common Stock |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2022 | 628 | 9,757 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2021 | 1,444 | 8,011 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2021 | 1,444 | 1,444 | - | - | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2021 | 1,418 | 2,835 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Mar 2021 | 1,418 | 8,790 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2021 | 639 | 7,372 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 06 Mar 2021 | 628 | 8,162 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2021 | 804 | 6,944 (0%) | 0% | 0 | Common Stock | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Feb 2021 | 804 | 0 | - | - | Performance Shares | |
| ICU Medical, Inc. | Daniel Woolson | VP, GM-Infusion Capital | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.00 per share. | 18 Feb 2021 | 377 | 6,567 (0%) | 0% | 0 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges